Literature DB >> 29143944

One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date.

Vinay Gunnala1, Mohamad Irani2, Alexis Melnick2, Zev Rosenwaks2, Steven Spandorfer2.   

Abstract

PURPOSE: The purpose of this study was to determine IVF outcomes in women 45 years and older using autologous oocytes.
METHODS: This is a retrospective cohort study reviewing all IVF cycles in women ≥ 45 years old from January 1995 to June 2015 that were conducted at one academic medical center. One thousand seventy-eight fresh, autologous IVF cycles met inclusion criteria. PGD/S, natural IVF, and donor egg cycles were excluded. Outcomes were analyzed for the different age groups (age 45, n = 773; age 46, n = 221; age 47, n = 57; age 48, n = 22; age 49, n = 5). Primary outcome measures included IVF cycle characteristics, total pregnancy loss, clinical pregnancy, and live birth rates, and were stratified according to patient age.
RESULTS: Mean age of patients in the study cohort was 45.4 ± 0.72. 11.7% of patients did not start due to an elevated FSH or cyst and 28.5% of patients were canceled prior to oocyte retrieval. The overall pregnancy rate per transfer was 18.7% (117/626), of which 82.1% ended in a pregnancy loss. The overall clinical pregnancy and live birth rates per transfer were 9.6 and 3.4%, respectively, which did not differ between age groups. Per cycle start women aged 45 had significantly higher positive pregnancy rates compared to women aged 46 and 47 (14.1 vs. 8.6 vs. 5.9%, p = 0.04). For women 45 years old, the live birth rate was 2.9% per cycle start and was 4.4% per embryo transfer. Of the 21 live births, 20 were in women aged 45 and one live birth was in a 46-year-old woman. There were no live births in any patient with ≤ 4 oocytes retrieved.
CONCLUSION: Autologous IVF in women aged 45 with acceptable ovarian reserve is not futile; however, it does carry very low prognosis. Patients aged 46 and older should be counseled appropriately that a live birth seems highly unlikely.

Entities:  

Keywords:  ART; Advanced maternal age; Advanced reproductive age; Age 45 and older; Autologous IVF

Mesh:

Year:  2017        PMID: 29143944      PMCID: PMC5904061          DOI: 10.1007/s10815-017-1088-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  28 in total

1.  Age-dependent decrease in embryo implantation rate after in vitro fertilization.

Authors:  R J van Kooij; C W Looman; J D Habbema; M Dorland; E R te Velde
Journal:  Fertil Steril       Date:  1996-11       Impact factor: 7.329

2.  GnRH antagonist-based protocols for in vitro fertilization.

Authors:  David Reichman; Zev Rosenwaks
Journal:  Methods Mol Biol       Date:  2014

Review 3.  The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.

Authors:  Jason M Franasiak; Eric J Forman; Kathleen H Hong; Marie D Werner; Kathleen M Upham; Nathan R Treff; Richard T Scott
Journal:  Fertil Steril       Date:  2013-12-17       Impact factor: 7.329

Review 4.  Management of infertility in women over 40.

Authors:  Rosalie Cabry; Philippe Merviel; Andre Hazout; Stephanie Belloc; Alain Dalleac; Henri Copin; Moncef Benkhalifa
Journal:  Maturitas       Date:  2014-03-05       Impact factor: 4.342

5.  Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.

Authors:  A Tsafrir; A Simon; A Revel; B Reubinoff; A Lewin; N Laufer
Journal:  Reprod Biomed Online       Date:  2007-03       Impact factor: 3.828

6.  Live birth in a 50-year-old woman following in vitro fertilization-embryo transfer with autologous oocytes: a rare case report.

Authors:  Geetha Rani; Sourendra Goswami; Ratna Chattopadhyay; Sanghamitra Ghosh; Baidyanath Chakravarty; Ashalatha Ganesh
Journal:  Fertil Steril       Date:  2014-12-13       Impact factor: 7.329

7.  In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.

Authors:  Carmen Rubio; José Bellver; Lorena Rodrigo; Gema Castillón; Alfredo Guillén; Carmina Vidal; Juan Giles; Marcos Ferrando; Sergio Cabanillas; José Remohí; Antonio Pellicer; Carlos Simón
Journal:  Fertil Steril       Date:  2017-04-19       Impact factor: 7.329

8.  No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy.

Authors:  Moniek Twisk; Sebastiaan Mastenbroek; Annemieke Hoek; Maas-Jan Heineman; Fulco van der Veen; Patrick M Bossuyt; Sjoerd Repping; Johanna C Korevaar
Journal:  Hum Reprod       Date:  2008-06-21       Impact factor: 6.918

9.  Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.

Authors:  Gamal Serour; Ragaa Mansour; Ahmed Serour; Mona Aboulghar; Yahia Amin; Omnia Kamal; Hesham Al-Inany; Mohamed Aboulghar
Journal:  Fertil Steril       Date:  2009-11-06       Impact factor: 7.329

10.  Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes.

Authors:  Franck Pellestor; Brigitte Andréo; Françoise Arnal; Claude Humeau; Jacques Demaille
Journal:  Hum Genet       Date:  2002-10-29       Impact factor: 4.132

View more
  3 in total

1.  Why is use of donor eggs not viewed as treatment failure? A call for improvements in treatments with autologous oocytes.

Authors:  Norbert Gleicher; David H Barad; Eli Y Adashi
Journal:  J Assist Reprod Genet       Date:  2020-06-06       Impact factor: 3.412

2.  Predictive Factors for Live Birth in Autologous in Vitro Fertilization Cycles in Women Aged 40 Years and Older.

Authors:  Milan Reljič; Vida Gavrić Lovrec
Journal:  Zdr Varst       Date:  2019-10-01

3.  Body mass index is not associated with donor oocyte recipient success: an ideal study using a paired analysis of sibling-oocytes.

Authors:  Robert Setton; Alice Chung; Lilli Zimmerman; Alexis Melnick; Zev Rosenwaks; Steven D Spandorfer
Journal:  F S Rep       Date:  2020-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.